196 related articles for article (PubMed ID: 17009848)
1. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.
Glunde K; Ackerstaff E; Mori N; Jacobs MA; Bhujwalla ZM
Mol Pharm; 2006; 3(5):496-506. PubMed ID: 17009848
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.
Shah T; Stasinopoulos I; Wildes F; Kakkad S; Artemov D; Bhujwalla ZM
NMR Biomed; 2012 May; 25(5):746-54. PubMed ID: 21953546
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.
Glunde K; Serkova NJ
Pharmacogenomics; 2006 Oct; 7(7):1109-23. PubMed ID: 17054420
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.
Glunde K; Jie C; Bhujwalla ZM
Neoplasia; 2006 Sep; 8(9):758-71. PubMed ID: 16984733
[TBL] [Abstract][Full Text] [Related]
5. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
6. Choline metabolism in cancer: implications for diagnosis and therapy.
Glunde K; Jacobs MA; Bhujwalla ZM
Expert Rev Mol Diagn; 2006 Nov; 6(6):821-9. PubMed ID: 17140369
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.
Shin HJ; Baek HM; Cha JH; Kim HH
AJR Am J Roentgenol; 2012 May; 198(5):W488-97. PubMed ID: 22528931
[TBL] [Abstract][Full Text] [Related]
8. Application of in vivo MR methods in the study of breast cancer metabolism.
Jagannathan NR
NMR Biomed; 2019 Oct; 32(10):e4032. PubMed ID: 30456917
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
[TBL] [Abstract][Full Text] [Related]
10. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
[TBL] [Abstract][Full Text] [Related]
11. Choline phospholipid metabolism: a target in cancer cells?
Ackerstaff E; Glunde K; Bhujwalla ZM
J Cell Biochem; 2003 Oct; 90(3):525-33. PubMed ID: 14523987
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopy in cancer: phospholipid, neutral lipid and lipoprotein metabolism and function.
Podo F; de Certaines JD
Anticancer Res; 1996; 16(3B):1305-15. PubMed ID: 8694495
[TBL] [Abstract][Full Text] [Related]
13. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.
Sonkar K; Ayyappan V; Tressler CM; Adelaja O; Cai R; Cheng M; Glunde K
NMR Biomed; 2019 Oct; 32(10):e4112. PubMed ID: 31184789
[TBL] [Abstract][Full Text] [Related]
14. Choline metabolism in malignant transformation.
Glunde K; Bhujwalla ZM; Ronen SM
Nat Rev Cancer; 2011 Nov; 11(12):835-48. PubMed ID: 22089420
[TBL] [Abstract][Full Text] [Related]
15. Choline-based imaging of prostate cancer with combined [
Wetter A; Grüneisen J; Fliessbach K; Lütje S; Schaarschmidt B; Umutlu L
Clin Imaging; 2017; 42():198-202. PubMed ID: 28110202
[TBL] [Abstract][Full Text] [Related]
16. MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.
Glunde K; Jiang L; Moestue SA; Gribbestad IS
NMR Biomed; 2011 Jul; 24(6):673-90. PubMed ID: 21793073
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment.
He Q; Xu RZ; Shkarin P; Pizzorno G; Lee-French CH; Rothman DL; Shungu DC; Shim H
Dis Markers; 2003-2004; 19(2-3):69-94. PubMed ID: 15096706
[TBL] [Abstract][Full Text] [Related]
18. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study.
Baio G; Rescinito G; Rosa F; Pace D; Boccardo S; Basso L; Salvi S; Calabrese M; Truini M; Neumaier CE
Mol Imaging Biol; 2015 Aug; 17(4):548-56. PubMed ID: 25613673
[TBL] [Abstract][Full Text] [Related]
20. Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway.
Trousil S; Lee P; Pinato DJ; Ellis JK; Dina R; Aboagye EO; Keun HC; Sharma R
Cancer Res; 2014 Dec; 74(23):6867-77. PubMed ID: 25267063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
